v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating expenses:    
Research and development $ 15,330 $ 17,441
General and administrative 3,689 4,123
Total operating expenses 19,019 21,564
Loss from operations (19,019) (21,564)
Other income (expense):    
Interest income, net 980 1,935
Other income (expense), net 1 (4)
Total other income 981 1,931
Loss before (benefit) provision for income taxes (18,038) (19,633)
(Benefit) provision for income taxes   (2,197)
Net loss (18,038) (17,436)
Unrealized loss on available for sale investments, net of tax (101) (62)
Foreign currency translation gain 2 7
Total other comprehensive loss (99) (55)
Total comprehensive loss $ (18,137) $ (17,491)
Net loss per share - basic $ (0.34) $ (0.34)
Net loss per share - diluted $ (0.34) $ (0.34)
Weighted-average common shares outstanding - basic 53,331,766 51,952,062
Weighted-average common shares outstanding - diluted 53,331,766 51,952,062